SCHEMBL17508472

SCHEMBL17508472

FC(F)(F)c1cccc(Oc2cccc3ccncc23)c1

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HPGD P15428 1/20 0.47
MAPT P10636 3/20 0.46
ICAM1 P05362 1/20 0.46
SELE P16581 1/20 0.46
SUCNR1 Q9BXA5 1/20 0.44
ABCG2 Q9UNQ0 1/20 0.43
PPP1CA P62136 1/20 0.43
KMT2A Q03164 1/20 0.43
L3MBTL1 Q9Y468 3/20 0.42
ALDH1A1 P00352 1/20 0.42
POLB P06746 1/20 0.42
NPSR1 Q6W5P4 2/20 0.42
CYP1A2 P05177 1/20 0.41
CYP2C9 P11712 1/20 0.41
CYP2C19 P33261 1/20 0.41
TRPV1 Q8NER1 1/20 0.40
NTRK1 P04629 1/20 0.40
ADORA2A P29274 1/20 0.40
F10 P00742 1/20 0.40
KIF11 P52732 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9272721 0.79 TNF (0.53) MAPTALDH1A1
SCHEMBL17508474 0.77 MAPT (0.53) MAPTKMT2AL3MBTL1CYP1A2CYP2C9
SCHEMBL6201456 0.75 BRAF (0.58) MAPTABCG2L3MBTL1ALDH1A1POLB
SCHEMBL17508503 0.74 L3MBTL1 (0.43) HPGDMAPTABCG2PPP1CAKMT2A
SCHEMBL17508487 0.74 BCHE (0.43) HPGDMAPTICAM1SELEABCG2
SCHEMBL17524601 0.74 BCHE (0.43) HPGDMAPTICAM1SELEABCG2
SCHEMBL20502303 0.73 SUCNR1 (0.71) SUCNR1TRPV1
SCHEMBL30298696 0.73 ICAM1 (0.59) MAPTICAM1SELEKMT2AL3MBTL1
SCHEMBL10969028 0.73 ICAM1 (0.56) MAPTICAM1SELEKMT2AL3MBTL1
SCHEMBL30341576 0.73 ICAM1 (0.59) MAPTICAM1SELEKMT2AL3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2016021742-A1 HETEROCYCLIC COMPOUNDS AS EP4 RECEPTOR ANTAGONISTS TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2016-02-11 WO disclosed
WO-2016021742-A1 HETEROCYCLIC COMPOUNDS AS EP4 RECEPTOR ANTAGONISTS TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2016-02-11 WO disclosed